Center for Cancer Biology (CCB) (formerly Vesalius Research Center (VRC))
Research facility
Location:
Leuven,
Belgium (BE)
ISNI: 000000404749326
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk (2015)
Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, et al.
Journal article
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015)
Lei J, Rudolph A, Moysich KB, Rafiq S, Behrens S, Goode EL, Pharoah PP, et al.
Journal article
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy (2014)
Li J, Lindstroem LS, Foo JN, Rafiq S, Schmidt MK, Pharoah PDP, Michailidou K, et al.
Journal article